TEODORI, ELISABETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.206
EU - Europa 8.374
AS - Asia 1.890
AF - Africa 78
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 21.559
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.180
RU - Federazione Russa 2.641
PL - Polonia 1.582
IE - Irlanda 1.024
SE - Svezia 935
IT - Italia 858
HK - Hong Kong 509
SG - Singapore 491
CN - Cina 372
UA - Ucraina 369
DE - Germania 306
FI - Finlandia 244
VN - Vietnam 199
IN - India 175
GB - Regno Unito 166
CH - Svizzera 82
CI - Costa d'Avorio 48
JO - Giordania 47
TR - Turchia 41
FR - Francia 37
KR - Corea 36
BE - Belgio 33
ES - Italia 30
NL - Olanda 28
CA - Canada 26
SC - Seychelles 17
RO - Romania 14
AT - Austria 6
DZ - Algeria 6
HR - Croazia 5
JP - Giappone 5
CZ - Repubblica Ceca 4
MO - Macao, regione amministrativa speciale della Cina 4
MU - Mauritius 4
HU - Ungheria 3
AR - Argentina 2
EG - Egitto 2
EU - Europa 2
IL - Israele 2
IR - Iran 2
LV - Lettonia 2
TW - Taiwan 2
A1 - Anonimo 1
AU - Australia 1
BG - Bulgaria 1
CL - Cile 1
CO - Colombia 1
EC - Ecuador 1
GR - Grecia 1
KE - Kenya 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
RS - Serbia 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 21.559
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.927
Warsaw 1.578
Fairfield 1.135
Chandler 1.075
Dublin 1.020
Ashburn 764
Jacksonville 546
Woodbridge 519
Cambridge 496
Seattle 456
Houston 445
Wilmington 408
Singapore 368
Hong Kong 315
Ann Arbor 264
Princeton 240
Dong Ket 193
Boston 186
Altamura 180
Florence 169
Mumbai 152
Lawrence 150
Boardman 123
Buffalo 118
Beijing 110
Medford 92
Moscow 78
Shanghai 74
Bern 71
San Diego 61
Abidjan 48
Kent 42
Norwalk 41
New York 39
Helsinki 37
Izmir 36
Milan 35
Los Angeles 34
Washington 34
Falls Church 33
Munich 32
Brussels 30
Guangzhou 28
Barcelona 27
Andover 26
Philadelphia 26
Frankfurt Am Main 25
Hillsboro 25
Lappeenranta 22
Phoenix 22
West Jordan 22
Seongnam 20
Verona 19
Yubileyny 19
Rome 16
Toronto 16
Redwood City 14
Pune 13
London 12
Salerno 12
Gavirate 11
Seoul 11
Auburn Hills 9
Düsseldorf 8
Frankfurt am Main 7
Ottawa 7
Romola 7
Treviglio 7
Groningen 6
Misano Adriatico 6
Siena 6
Cedar Knolls 5
Grafing 5
Laurel 5
Napoli 5
Parma 5
Tappahannock 5
Edinburgh 4
Genoa 4
Giugliano In Campania 4
Leawood 4
Macao 4
Menlo Park 4
Nanjing 4
Nuremberg 4
Scandicci 4
Sesto Fiorentino 4
Vienna 4
Acton 3
Amherst 3
Amsterdam 3
Bologna 3
Budapest 3
Calvisano 3
Hanover 3
Iclod 3
Naples 3
Redmond 3
Reggio Emilia 3
San Martino Buon Albergo 3
Totale 14.313
Salva come PNG Salva come JPEG
Nome #
Molecular simplification of 1,4-diazabicyclo[4.3.0]nonan-9-ones gives piperazine derivatives that maintain high nootropic activity 300
4-Aminopiperidine derivatives as a new class of potent cognition enhancing drugs 287
S(-)ET126: a potent and selective M1 antagonist in vitro and in vivo 261
The functions and structure of ABC transporters: implications for the design of new inhibitors of Pgp and MRP1 to control multidrug resistance (MDR) 253
Presynaptic Cholinergic Modulators as Potent Cognition Enhancers and Analgesic Drugs. 2. 2-Phenoxy-, 2-(phenylthio)- and 2-(phenylamino)alkanoic Acid Esters 234
Novel functionalized organotellurides with enhanced thiol peroxidase catalytic activity 226
Design, synthesis and preliminary pharmacological evaluation of 1,4-diazabicyclo[4.3.0]nonan-9-ones as a new class of highly potent nootropic drugs. 222
An easy one-step procedure for the synthesis of novel beta-functionalised tellurides 222
Are the contractions of rabbit peripheral lung, guinea-pig gall-bladder and guinea-pig uterus mediated by identical receptor subtype? 208
Binding Profiles of a Series of 2-Arylpropionic Acid Esters on Cloned Human Muscarinic Receptors Subtypes (m1-m5) and Their Relationship to Nootropic Activity 199
THE FROZEN ANALOG APPROACH IN MEDICINAL CHEMISTRY 193
Amino acids as building blocks for carbonic anhydrase inhibitors 193
Design, synthesis and biological evaluation of stereo- and regioisomers of amino aryl esters as multidrug resistance (MDR) reversers 170
Recent advances in the search of BCRP- and dual P-gp/BCRP-based multidrug resistance modulators 162
N,N-bis(cyclohexanol)amine aryl esters: the discovery of a new class of highly potent inhibitors of transporter-dependent multidrug resistance (MDR) 158
Multidrug resistance (MDR) reversers: High activity and efficacy in a series of asymmetrical N,N-bis(alkanol)amine aryl esters 156
Design, synthesis and preliminary biological evaluation of new isoform-selective f-current blockers. 147
1-benzyl-1,4-diazepane reduces the efflux of resistance-nodulation-cell division pumps in Escherichia coli 145
2-Benzylpiperazine: a new scaffold for potent human Carbonic Anhydrase inhibitors. Synthesis, enzyme inhibition, enantioselectivity, computational and crystallographic studies and in vivo activity for a new class of intraocular pressure lowering agents. 145
1,3-oxathiolane muscarinic ligands modified at the cationic head. 143
Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug-resistance (MDR) modulators 142
Energy resolved tandem mass spectrometry experiments for resolution of isobaric compounds: a case of cis/trans isomerism 141
Design, Synthesis, and Preliminary Pharmacological Evaluation of New Quinoline Derivatives as Nicotinic Ligands 139
Highly chiral muscarinic ligands: the discovery of (2S,2'R,3'S,5'R)-1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine 3-sulfoxide methyl iodide, a potent, functionally selective, M2 partial agonist. 138
Design and synthesis of new potent N,N-bis(arylalkyl)piperazine derivatives as multidrug resistance (MDR) reversing agents 136
1H-pyrrolo[2,3-b]pyridine: a new scaffold for human neutrophil elastase (HNE) inhibitors 135
Synthesis and Cholinergic Affinity of Diastereomeric and Enantiomeric Isomers of 1-Methyl-2-(2-methyl-1,3-dioxolan-4-yl)-pyrrolidine, 1-Methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine and of Their Iodomethylates 135
ISOMERIC N,N-BIS(CYCLOHEXANOL)AMINE ARYL ESTERS: THE DISCOVERY OF A NEW CLASS OF HIGHLY POTENT P-GLYCOPROTEIN (PGP)-DEPENDENT MULTIDRUG RESISTANCE (MDR) INHIBITORS 134
Antagonisti muscarinici a struttura 1,3-ossatiolano-2-pirrolidinica 134
N,N-Bis(cyclohexanol) amine aryl esters inhibit P-glycoprotein as transport substrates 134
New structure–activity relationship studies in a series of N,N-bis(cyclohexanol)amine aryl esters as potent reversers of P-glycoprotein-mediated multidrug resistance (MDR) 133
SYNTHESIS, AFFINITY PROFILE AND FUNCTIONAL ACTIVITY OF MUSCARINIC ANTAGONISTS WITH A 1-METHYL-2-(2,2-ALKYLARYL-1,3-OXATHIOLAN-5-YL)PYRROLIDINE STRUCTURE 133
FURTHER STRUCTURE-ACTIVITY RELATIONSHIPS IN THE SERIES OF TROPANYL ESTERS ENDOWED WITH POTENT ANTINOCICEPTIVE ACTIVITY 132
(1,3-Dioxolane)- and (1,3-oxathiolane)-2-pyrrolidines: molecular hybrids with potential anti-Alzheimer activity 132
13C NMR SPECTRA OF 1,3-OXATHIOLANE, 1,3-OXATHIOLANE-3-OXIDE AND 1,3-OXATHIOLANE-3,3-DIOXIDE DERIVATIVES 131
Chiral synthesis and pharmacological evaluation of the enantiomers of SM32, a new analgesic and cognition-enhancing agent. 131
Design, synthesis and preliminary biological evaluation of zatebradine analogues as potential blockers of the hyperpolarization-activated current 130
Synthesis and carbonic anhydrase activating properties of a series of 2-amino-imidazolines structurally related to clonidine 129
Synthesis and Enantioselectivity of the Enantiomers of PG9 and SM21, New Potent Analgesic and Cognition-Enhancing Drugs 127
Carbachol dimers as homobivalent modulators of muscarinic receptors 125
Design and synthesis of aminoester heterodimers containing flavone or chromone moieties as modulators of P-glycoprotein-based multidrug resistance (MDR) 124
Dual P-glycoprotein and CA XII inhibitors: A new strategy to reverse the P-gp Mediated Multidrug Resistance (MDR) in cancer cells y 122
The medicinal chemistry of multidrug resistance (MDR) reversing drugs 122
Diphenylcyclohexylamine derivatives as new potent multidrug resistance (MDR) modulators 121
SAR STUDIES ON THE POTENT AND SELECTIVE MUSCARINIC ANTAGONIST 2-ETHYLTHIO-2,2-DIPHENYLACETIC ACID N,N-DIETHYLAMINOETHYL ESTER 119
Design of novel nicotinic ligands through 3D database searching 119
Design, synthesis and nootropic activity of new analogues of sunifiram and sapunifiram, two potent cognition-enhancers. 119
DIFFERENTIAL ANALGESIC ACTIVITY OF THE ENANTIOMERS OF ATROPINE DERIVATIVES DOES NOT CORRELATE WITH THEIR MUSCARINIC SUBTYPE SELECTIVITY 119
1,4-Diazabicyclo[4.3.0]nonan-9-ones and 1,4-diamidopiperazines as new classes of highly potent nootropic drugs 119
PRESYNAPTIC AUTO- AND HETERO-RECEPTORS IN THE CHOLINERGIC REGULATION OF PAIN 118
6,7-Dimethoxy-2-phenethyl-1,2,3,4-tetrahydroisoquinoline amides and corresponding ester isosteres as multidrug resistance reversers 118
Presynaptic Cholinergic Modulators as Potent Cognition Enhancers and Analgesic Drugs. 1. Tropic and 2-Phenylpropionic Acid Esters 117
Design, synthesis and preliminary evaluation of a series of histone deacetylase inhibitors carrying a benzodiazepine ring 117
SEMI-RIGID ANALOGUES OF THE CALCIUM ANTAGONIST VERAPAMIL: A MOLECULAR MODELLING STUDY 116
N-alkanol-N-cyclohexanol amine aryl esters: Multidrug resistance (MDR) reversing agents with high potency and efficacy 116
1,4-Diazabicyclo[4.3.0]nonan-9-ones as a new class of highly potent nootropic drugs 116
"Synthesis and binding properties of photoactivable Biotin-conjugated verapamil derivatives for the study of P-170 glycoprotein" 115
Muscarinic antagonists with multiple stereocenters: synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivatives 115
EC18 as a Tool To Understand the Role of HCN4 Channels in Mediating Hyperpolarization-Activated Current in Tissues 115
N,N-bis(cyclohexanol)amine aryl esters: a new class of highly potent Pgp-dependent multidrug resistance (MDR) inhibitors 113
Muscarinic subtype affinity and functional activity profile of 1-methyl-2-(2-methyl-1,3-dioxolan-4-yl)pyrrolidine and 1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine derivatives. 112
ANTIAMNESIC ACTIVITY OF METOCLOPRAMIDE, CISAPRIDE AND SR-17 IN THE MOUSE PASSIVE AVOIDANCE TEST 111
Designing selective modulators for the nicotinic receptor subtypes: challenges and opportunities 110
Structure-Activity Relationship Studies on 6,7-Dimethoxy-2-phenethyl-1,2,3,4-tetrahydroisoquinoline Derivatives as Multidrug Resistance Reversers 109
Design, synthesis and preliminary pharmacological evaluation of a set of small molecules that directly activate Gi proteins. 109
Synthesis of Hexahydro-[2]pyrindine(=Hexahydrocyclopenta[c]pyridine) Derivatives as Conformationally Restricted Analogs of the Nicotinic Ligands Arecolone and Isoarecolone 109
VERAPAMIL ANALOGUES WITH RESTRICTED MOLECULAR FLEXIBILITY: SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF THE FOUR ISOMERS OF ALPHA-[1-[3-[N-[1-[2-(3,4-DIMETHOXYPHENYL)ETHYL]]-N-METHYLAMINO]CYCLOHEXYL]]-ALPHA-ISOPROPYL-3,4-DIMETHOXYBENZENEACETONITRILE 108
Arylamino Esters as P-Glycoprotein Modulators: SAR Studies to Establish Requirements for Potency and Selectivity 108
Design, synthesis and preliminary pharmacological evaluation of new piperidine and piperazine derivatives as cognition-enhancers 107
Enantioselective synthesis and preliminary pharmacological evaluation of the enantiomers of unifiram (DM232), a potent cognition-enhancing agent 107
UNEXPECTED REACTIONS OF 2-NITRO-FLUORENE-9-CARBOXYLIC ACID 106
REDUCED FLEXIBILITY ANALOGS OF ANALGESIC AND COGNITION-ENHANCING A-TROPANYL ESTERS 106
Sulfonamides incorporating piperazine bioisosteres as potent human carbonic anhydrase I, II, IV and IX inhibitors 105
The power of energy-resolved tandem mass spectrometry experiments for resolution of isomers: the case of drug plasma stability investigation of multidrug resistance inhibitors 105
In vitro and in silico analysis of the vascular effects of asymmetrical N,N-bis(alkanol)amine aryl esters, novel multidrug-resistance reverting agents 105
STRUCTURAL DEPENDENCE OF THE ALLOSTERIC INTERACTION OF SEMI-RIGID VERAPAMIL ANALOGUES WITH DIHYDROPYRIDINE-BINDING IN KITTEN HEART 104
New 3-unsubstituted Isoxazolones as Potent Human Neutrophil Elastase Inhibitors: Synthesis and Molecular Dynamic Simulation 104
ANALGESIC, ANTIMUSCARINIC ACTIVITY AND ENANTIOSELECTIVITY OF THE FOUR ISOMERS OF 3-QUINUCLIDINYL TROPATE AS COMPARED WITH THE ENANTIOMERS OF HYOSCYAMINE 103
Structure-activity relationships in 2,2-diphenyl-2-ethylthioacetic acid esters: unexpected agonistic activity in a series of muscarinic antagonists. 103
Inhibition of P-glycoprotein-mediated Multidrug Resistance (MDR) by N,N-bis(cyclohexanol)amine aryl esters: further restriction of molecular flexibility maintains high potency and efficacy 103
In vitro and in silico analysis of the vascular effects of asymmetrical N,N-bis(alkanol)amine aryl esters, novel multidrug resistance-reverting agents 103
Substituted piperazines as nootropic agents: 2- or 3-phenyl derivatives structurally related to the cognition-enhancer DM235 102
Design, synthesis and preliminary pharmacological evaluation of 4-aminopiperidine derivatives as N-type calcium channel blockers active on pain and neuropathic pain 102
MOLECULAR MODULATION OF MUSCARINIC ANTAGONISTS. SYNTHESIS AND PHARMACOLOGICAL PROFILE OF 2,2-DIPHENYL-2-ETHYLTHIOACETIC AND 3,3-DIPHENYL-3-ETHYLTHIOPROPIONIC ACID DERIVATIVES CHARACTERIZED BY A DIPEPTIDE SPACER 101
Design, synthesis and preliminary pharmacological evaluation of new analogues of DM232 (unifiram) and DM235 (sunifiram) as cognition modulators. 101
Design, synthesis and preliminary pharmacological evaluation of new analogues of DM232 (unifiram) and DM235 (sunifiram) as cognition modulators 100
Synthesis and pharmacological evaluation of some (pyridyl)cyclopropylmethyl amines and their methiodides as nicotinic receptor ligands. 100
Structure-activity relationship studies on unifiram (DM232) and sunifiram (DM235), two novel and potent cognition enhancing drugs 99
"Partial inhibition of the P-glycoprotein-mediated transport of anthracyclines in viable resistant K562 cells after irradiation in the presence of a verapamil analogue" 99
Influence of ring size on the cognition-enhancing activity of DM235 and MN19, two potent nootropic drugs 99
1,5,6,7-Tetrahydro-4H-indazol-4-ones as human neutrophil elastase (HNE) inhibitors 99
Piperazines as nootropic agents: New derivatives of the potent cognition-enhancer DM235 carrying hydrophilic substituents 98
Synthesis and Biological Evaluation of 3,7-Diazabicyclo[4.3.0]2 nonan-8-ones as Potential Nootropic and Analgesic Drugs 96
New phenylalkylamines as isoform selective HCN-Channels blockers 96
Design, synthesis and pharmacological evaluation of some frozen-analogues of DMPP 96
New quinoline derivatives as nicotinic receptor modulators 96
2-(2-Hydroxyethyl)piperazine derivatives as potent human carbonic anhydrase inhibitors: Synthesis, enzyme inhibition, computational studies and antiglaucoma activity 96
Synthesis, Affinity Profile and Functional Activity of Potent Chiral Muscarinic Antagonists with a Pyrrolidinylfuran Structure 95
Design, synthesis and preliminary biological evaluation of new hydroxamate histone deacetylase inhibitors as potential antileukemic agents. 95
SYNTHESIS AND BIOLOGICAL ACTIVITY OF A SERIES OF ARYL TROPANYL ESTERS AND AMIDES CHEMICALLY RELATED TO 1H-INDOLE-3-CARBOXYLIC ACID ENDO 8-METHYL-8-AZABICYCLO[3.2.1]OCT-3-YL ESTER 94
Totale 13.156
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.490
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.490
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.022 0 0 0 0 293 339 269 359 257 173 276 56
2020/20212.376 181 142 155 241 62 305 85 219 187 353 124 322
2021/20221.563 53 196 102 57 40 51 74 99 51 52 347 441
2022/20234.097 389 619 190 315 321 787 537 249 426 23 131 110
2023/20241.768 57 181 264 93 116 353 54 398 31 65 78 78
2024/20256.108 379 1.078 683 1.463 2.505 0 0 0 0 0 0 0
Totale 21.886